Physical characteristics of freeze-dried griseofulvin-lipids nanoparticles

Chemical and Pharmaceutical Bulletin

Volumn 54, Issue 2, 2006, Pages 181-184

  Kamiya, Seitaro ^a   Nozawa, Yasuo ^a   Miyagishima, Astuo ^a   Kurita, Takurou ^a   Sadzuka, Yasuyuki ^a   Sonobe, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Freeze drying; High pressure homogenization; Nanoparticle; Rehydration; Sugar

Indexed keywords

DISACCHARIDE; GRISEOFULVIN; MALTOSE; MONOSACCHARIDE; NANOPARTICLE; SUCROSE; SUGAR; TREHALOSE;

ARTICLE; CRYSTAL; DRUG SOLUBILITY; DRUG STORAGE; FREEZE DRYING; HYDRATION; MOLECULAR MECHANICS; PARTICLE SIZE; POWDER DIFFRACTION; PRESSURE; STORAGE TEMPERATURE; X RAY DIFFRACTION;

EID: 32044471321     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.54.181     Document Type: Article

References (26)

1. Kim C. K., Cho Y. J., Gao Z. G., J. Control. Release, 70, 149-155 (2001).
2. Kawakami K., Miyoshi K., Ida Y., J. Pharm. Sci., 93, 1471-1479 (2004).
3. Yamada T., Saito N., Imai T., Otagiri M., Chem. Pharm. Bull., 47, 1311-1313 (1999).
4. Saito M., Ugajin T., Nozawa Y., Sadzuka Y., Miyagishima A., Sonobe T., Int. J. Pharm., 249, 71-79 (2002).
5. Eyjolfsson R., Drug Dev. Ind. Pharm., 25, 105-106 (1999).
6. Law D., Wang W., Schmitt E. A., Qiu Y., Krill S. L., Fort J. J., J. Pharm. Sci., 92, 505-515 (2003).
7. Desai M. P., Labhasetwar V., Amidon G. L., Levy R. J., Pharm. Res., 13, 1838-1845 (1996).
8. Chattopadhyay P., Gupta R. B., Int. J. Pharm., 228, 19-31 (2001).
9. Crounse R. G., J. Invest. Dermatol., 37, 529-533 (1961).
10. Kraml M., Dubuc J., Guadry R., Antibiot. Chemother., 12, 239-242 (1962).
11. Atkinson R. M., Bedford C., Child K. J., Tomich E. G., Nature (London), 193, 588-589 (1962).
12. Peters K., Muller R. H., Craig D. Q., Int. J. Pharm., 184, 53-61 (1999).
13. Jacobs C., Kayser O., Muller R. H., Int. J. Pharm., 196, 161-164 (2000).
14. Hu L., Tang X., Cui F., J. Pharm. Pharmacol., 56, 1527-1535 (2004).
15. Fujii M., Bouno M., Fujita S., Yoshida M., Watanabe Y., Matsumoto M., Biol. Pharm. Bull., 23, 1341-1345 (2000).
16. Jani P., Halbert G. W., Langridge J., Florence A. T., J. Pharm. Pharmacol., 42, 821-826 (1990).
17. Nozawa Y., Kamiya S., Sadzuka Y., Miyagishima A., Sonobe T., Kagaku Kogaku Ronbunshu, 30, 43-46 (2004).
18. Pacheco L. F., Carmona-Ribeiro A. M., J. Colloid Interface Sci., 258, 146-154 (2003).
19. Moreno M. A., Frutos P., Ballesteros M. P., Pharm. Res., 18, 344-351 (2001).
20. Schaffazick S. R., Pohlmann A. R., Dalla-Costa T., Guterres S. S., Eur. J. Pharm. Biopharm., 56, 501-505 (2003).
21. Konan Y. N., Gurny R., Allemann E., Int. J. Pharm., 233, 239-252 (2002).
22. Jepson C. D., March J. B., Vaccine, 22, 2413-2419 (2004).
23. Allison S. D., Chang B., Randolph T. W., Carpenter J. F., Arch. Biochem. Biophys., 365, 289-298 (1999).
24. Kwok K. Y., Adam R. C., Hester K. C., Park Y., Thomas S., Rice K. G., Int. J. Pharm., 203, 81-88 (2000).
25. Imamura K., Iwai M., Ogawa T., Sakiyama T., Nakanishi K., J. Pharm. Sci., 90, 1955-1963 (2001).
26. Li B., Li S., Tan Y., Stolz D. B., Watkins S. C., Block L. H., Huang L., J. Pharm. Sci., 89, 355-364 (2000).